PLX4032 and melanoma: resistance, expectations and uncertainty
| dc.contributor.author | Roukos, D. H. | en |
| dc.date.accessioned | 2015-11-24T18:58:03Z | |
| dc.date.available | 2015-11-24T18:58:03Z | |
| dc.identifier.issn | 1744-8328 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/19239 | |
| dc.rights | Default Licence | - |
| dc.subject | Antineoplastic Agents/*therapeutic use | en |
| dc.subject | Drug Resistance, Neoplasm/*genetics | en |
| dc.subject | Humans | en |
| dc.subject | Indoles/*therapeutic use | en |
| dc.subject | Melanoma/*drug therapy/genetics | en |
| dc.subject | Mutation | en |
| dc.subject | Protein Kinase Inhibitors/*therapeutic use | en |
| dc.subject | Proto-Oncogene Proteins B-raf/genetics | en |
| dc.subject | Sulfonamides/*therapeutic use | en |
| dc.title | PLX4032 and melanoma: resistance, expectations and uncertainty | en |
| heal.access | campus | - |
| heal.fullTextAvailability | TRUE | - |
| heal.identifier.primary | 10.1586/era.11.3 | - |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/21417847 | - |
| heal.identifier.secondary | http://www.expert-reviews.com/doi/pdfplus/10.1586/era.11.3 | - |
| heal.journalName | Expert Rev Anticancer Ther | en |
| heal.journalType | peer-reviewed | - |
| heal.language | en | - |
| heal.publicationDate | 2011 | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.type | journalArticle | - |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: